# Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions

> **NCT01269281** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sumatriptan

## Key facts

- **NCT ID:** NCT01269281
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269281, "Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01269281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*